EU-funded researchers talk about innovative "superglue" cancer treatment
This interview with Erika Pineda Ramírez and Alba García-Fernández was originally published on the European Research Executive Agency website.
Inspired by personal experiences with cancer, researchers Alba García-Fernández and Erika Pineda Ramírez are working to develop a new type of immunotherapy known as NanoGlue.
Supported by the Marie Skłodowska-Curie Actions (MSCA) through the ARISTOS Postdoctoral Programme, the project explores how specially designed nanoparticles can help the immune system recognise and attack cancer cells more effectively.
This interview with Erika Pineda Ramírez and Alba García-Fernández was originally published on the European Research Executive Agency website.
Go to the European Research Executive Agency website to read the whole article.
Last updated: